Jiangsu KeyGEN BioTECH Co., Ltd. is a high-tech enterprise specializing in the development of bio-reagents, biotechnology service, and life science industrial service. It is also a national, branded bio-reagent supplier. The company focuses on basic life science research and translational medicine and has constructed two open innovation platforms of "KeyGEN" and "Titeca." In the bio-reagent industry, KeyGEN has covered the whole industry chain, from the development of raw material to product circulation.
KeyGEN invests 15% of its annual operating revenue in the R&D of bio-reagent. The company owns tens of innovation patents, including seven international patents in the U.S., Japan, and Europe. KeyGEN has also earned the ISO 9001 certification for its products and services. KeyGEN is the operator of several provincial and municipal common technology platforms, including the Jiangsu Diagnostic Reagent Research Center, Jiangsu Bio-Medicine Pubilc Service Platform, Nanjing Diagnostics, and Translational Medicine Public Technology Service Platform, CHINA-UK TOF-MS Diagnostic Technology Center, etc.
KeyGEN BioTECH always adheres to the development concept of "serve for science, benefit human life," committing to becoming a leading, branded domestic supplier of bio-reagent products and services. Relying on science and technology innovation and professional standardized operation, KeyGEN takes advantage of the two platforms, constantly bringing new technology and new products. KeyGEN commits itself to help the R&D innovation and entrepreneurship in the new medicine and health care industry and to achieve a more independent and controllable transformation of scientific and technological achievements.
technical service solutions
served institutions in China
automated production line